Sales Growth YoY (Last 12 Months): Cronos Group Inc. (CRON)

Public company logo of Cronos Corp (CRON)

Cronos Group Inc. maintains high financial stability due to its lack of debt and substantial cash reserves. The Canadian medical cannabis producer attracts talent through an innovative approach and flexible working conditions. However, aggressive market consolidation and an oversupply of raw materials are weighing on margins. The year-over-year revenue growth trend on a rolling basis reflects a dynamic where the indicator remains around 56.00.

Cronos (CRON) Sales Growth YoY (Last Twelve Months): for the period 02/11/2024 - 11/17/2026

thecronosgroup.com (CRON) - metric breakdowns and financial figures

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Analysis of all company metrics:Cronos Corp
Brand item of Cronos Group Inc.

This indicator measures the revenue growth rate over the last 12 months relative to the same period last year, allowing for an assessment of real business expansion regardless of seasonality. For Cronos Group Inc. (CRON), the LTM YoY commercial revenue growth reflects the effectiveness of market capture in Germany, Israel, and Canada, confirming the fundamental resilience of assets through rising demand for branded products.